Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era
Micro-Abstract The role of lymphocyte/monocyte ratio (LMR) in diffuse large B-cell lymphoma (DLBCL) is under investigation; its role in follicular lymphoma (FL) is unknown. We found a prognostic effect of LMR in FL and in DLBCL.
Gespeichert in:
| Veröffentlicht in: | Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2015-04, Vol.15 (4), p.208-213 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 213 |
|---|---|
| container_issue | 4 |
| container_start_page | 208 |
| container_title | Clinical lymphoma, myeloma and leukemia |
| container_volume | 15 |
| creator | Belotti, Angelo Doni, Elisa Bolis, Silvia Rossini, Fausto Casaroli, Ivana Pezzatti, Sara Pogliani, Enrico Maria Pioltelli, Pietro Enrico |
| description | Micro-Abstract The role of lymphocyte/monocyte ratio (LMR) in diffuse large B-cell lymphoma (DLBCL) is under investigation; its role in follicular lymphoma (FL) is unknown. We found a prognostic effect of LMR in FL and in DLBCL. |
| doi_str_mv | 10.1016/j.clml.2014.10.001 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1667345247</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S215226501400439X</els_id><sourcerecordid>1667345247</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-896e8db5cf55d2ea2cb4b69e18fa5754a220e26ea519294f389ad9c75f689edb3</originalsourceid><addsrcrecordid>eNp9Uk1v1DAQjRCIfsAf4IB85JKt7dhOLCEkurSAtFVXBSRuluNMWC9OvNhJ1f0nPfa39JfhsNsiceDk0fi9p5n3JsteETwjmIiT9cy4zs0oJiw1ZhiTJ9khJZzmVAj59LHm-CA7inGNcZkw8nl2QDkTVUHJYXa7hGA3KwjaoVPnfYMW226z8mY7wMmF7_8U6EoP1qNlgMaaIaLLcTC-A2R7dO6ds2Z0OuyJnUa6b9LX_d0H27ZjBLTQ4Qeg03wOzv1FLZMm9Eltgg4ruL-7ssN4Yztdo7OgX2TPWu0ivNy_x9m387Ov80_54vLj5_n7RW5YRYa8kgKqpuam5byhoKmpWS0kkKrVvORMU4qBCtCcSCpZW1RSN9KUvBWVhKYujrM3O91N8L9GiIPqbDRpUt2DH6MiQpQF45SVCUp3UBN8jAFatQlp3LBVBKspEbVWUyJqSmTqJbcT6fVef6w7aB4pDxEkwNsdANKW1xaCiiYZY5LXAcygGm__r__uH7pxtrdGu5-whbj2Y-iTf4qoSBVWX6abmE6CMIxZIb8XvwFJgrZG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1667345247</pqid></control><display><type>article</type><title>Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Belotti, Angelo ; Doni, Elisa ; Bolis, Silvia ; Rossini, Fausto ; Casaroli, Ivana ; Pezzatti, Sara ; Pogliani, Enrico Maria ; Pioltelli, Pietro Enrico</creator><creatorcontrib>Belotti, Angelo ; Doni, Elisa ; Bolis, Silvia ; Rossini, Fausto ; Casaroli, Ivana ; Pezzatti, Sara ; Pogliani, Enrico Maria ; Pioltelli, Pietro Enrico</creatorcontrib><description>Micro-Abstract The role of lymphocyte/monocyte ratio (LMR) in diffuse large B-cell lymphoma (DLBCL) is under investigation; its role in follicular lymphoma (FL) is unknown. We found a prognostic effect of LMR in FL and in DLBCL.</description><identifier>ISSN: 2152-2650</identifier><identifier>EISSN: 2152-2669</identifier><identifier>DOI: 10.1016/j.clml.2014.10.001</identifier><identifier>PMID: 25468321</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Murine-Derived - therapeutic use ; Antineoplastic Agents - therapeutic use ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Cyclophosphamide - therapeutic use ; Doxorubicin - therapeutic use ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Leukocyte Count ; Lymphocytes ; Lymphoma, Follicular - blood ; Lymphoma, Follicular - diagnosis ; Lymphoma, Follicular - drug therapy ; Lymphoma, Follicular - mortality ; Lymphoma, Large B-Cell, Diffuse - blood ; Lymphoma, Large B-Cell, Diffuse - diagnosis ; Lymphoma, Large B-Cell, Diffuse - drug therapy ; Lymphoma, Large B-Cell, Diffuse - mortality ; Male ; Middle Aged ; Monocytes ; Neoplasm Staging ; Outside of a clinical trial ; Prednisone - therapeutic use ; Prognosis ; Retrospective Studies ; Rituximab - therapeutic use ; Survival Analysis ; Treatment Outcome ; Tumor burden ; Tumor microenvironment ; Vincristine - therapeutic use ; Watch and wait ; Young Adult</subject><ispartof>Clinical lymphoma, myeloma and leukemia, 2015-04, Vol.15 (4), p.208-213</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-896e8db5cf55d2ea2cb4b69e18fa5754a220e26ea519294f389ad9c75f689edb3</citedby><cites>FETCH-LOGICAL-c481t-896e8db5cf55d2ea2cb4b69e18fa5754a220e26ea519294f389ad9c75f689edb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S215226501400439X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25468321$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Belotti, Angelo</creatorcontrib><creatorcontrib>Doni, Elisa</creatorcontrib><creatorcontrib>Bolis, Silvia</creatorcontrib><creatorcontrib>Rossini, Fausto</creatorcontrib><creatorcontrib>Casaroli, Ivana</creatorcontrib><creatorcontrib>Pezzatti, Sara</creatorcontrib><creatorcontrib>Pogliani, Enrico Maria</creatorcontrib><creatorcontrib>Pioltelli, Pietro Enrico</creatorcontrib><title>Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era</title><title>Clinical lymphoma, myeloma and leukemia</title><addtitle>Clin Lymphoma Myeloma Leuk</addtitle><description>Micro-Abstract The role of lymphocyte/monocyte ratio (LMR) in diffuse large B-cell lymphoma (DLBCL) is under investigation; its role in follicular lymphoma (FL) is unknown. We found a prognostic effect of LMR in FL and in DLBCL.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Monoclonal, Murine-Derived - therapeutic use</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Doxorubicin - therapeutic use</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Leukocyte Count</subject><subject>Lymphocytes</subject><subject>Lymphoma, Follicular - blood</subject><subject>Lymphoma, Follicular - diagnosis</subject><subject>Lymphoma, Follicular - drug therapy</subject><subject>Lymphoma, Follicular - mortality</subject><subject>Lymphoma, Large B-Cell, Diffuse - blood</subject><subject>Lymphoma, Large B-Cell, Diffuse - diagnosis</subject><subject>Lymphoma, Large B-Cell, Diffuse - drug therapy</subject><subject>Lymphoma, Large B-Cell, Diffuse - mortality</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Monocytes</subject><subject>Neoplasm Staging</subject><subject>Outside of a clinical trial</subject><subject>Prednisone - therapeutic use</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Rituximab - therapeutic use</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><subject>Tumor burden</subject><subject>Tumor microenvironment</subject><subject>Vincristine - therapeutic use</subject><subject>Watch and wait</subject><subject>Young Adult</subject><issn>2152-2650</issn><issn>2152-2669</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uk1v1DAQjRCIfsAf4IB85JKt7dhOLCEkurSAtFVXBSRuluNMWC9OvNhJ1f0nPfa39JfhsNsiceDk0fi9p5n3JsteETwjmIiT9cy4zs0oJiw1ZhiTJ9khJZzmVAj59LHm-CA7inGNcZkw8nl2QDkTVUHJYXa7hGA3KwjaoVPnfYMW226z8mY7wMmF7_8U6EoP1qNlgMaaIaLLcTC-A2R7dO6ds2Z0OuyJnUa6b9LX_d0H27ZjBLTQ4Qeg03wOzv1FLZMm9Eltgg4ruL-7ssN4Yztdo7OgX2TPWu0ivNy_x9m387Ov80_54vLj5_n7RW5YRYa8kgKqpuam5byhoKmpWS0kkKrVvORMU4qBCtCcSCpZW1RSN9KUvBWVhKYujrM3O91N8L9GiIPqbDRpUt2DH6MiQpQF45SVCUp3UBN8jAFatQlp3LBVBKspEbVWUyJqSmTqJbcT6fVef6w7aB4pDxEkwNsdANKW1xaCiiYZY5LXAcygGm__r__uH7pxtrdGu5-whbj2Y-iTf4qoSBVWX6abmE6CMIxZIb8XvwFJgrZG</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Belotti, Angelo</creator><creator>Doni, Elisa</creator><creator>Bolis, Silvia</creator><creator>Rossini, Fausto</creator><creator>Casaroli, Ivana</creator><creator>Pezzatti, Sara</creator><creator>Pogliani, Enrico Maria</creator><creator>Pioltelli, Pietro Enrico</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150401</creationdate><title>Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era</title><author>Belotti, Angelo ; Doni, Elisa ; Bolis, Silvia ; Rossini, Fausto ; Casaroli, Ivana ; Pezzatti, Sara ; Pogliani, Enrico Maria ; Pioltelli, Pietro Enrico</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-896e8db5cf55d2ea2cb4b69e18fa5754a220e26ea519294f389ad9c75f689edb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Monoclonal, Murine-Derived - therapeutic use</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Doxorubicin - therapeutic use</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Leukocyte Count</topic><topic>Lymphocytes</topic><topic>Lymphoma, Follicular - blood</topic><topic>Lymphoma, Follicular - diagnosis</topic><topic>Lymphoma, Follicular - drug therapy</topic><topic>Lymphoma, Follicular - mortality</topic><topic>Lymphoma, Large B-Cell, Diffuse - blood</topic><topic>Lymphoma, Large B-Cell, Diffuse - diagnosis</topic><topic>Lymphoma, Large B-Cell, Diffuse - drug therapy</topic><topic>Lymphoma, Large B-Cell, Diffuse - mortality</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Monocytes</topic><topic>Neoplasm Staging</topic><topic>Outside of a clinical trial</topic><topic>Prednisone - therapeutic use</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Rituximab - therapeutic use</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><topic>Tumor burden</topic><topic>Tumor microenvironment</topic><topic>Vincristine - therapeutic use</topic><topic>Watch and wait</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Belotti, Angelo</creatorcontrib><creatorcontrib>Doni, Elisa</creatorcontrib><creatorcontrib>Bolis, Silvia</creatorcontrib><creatorcontrib>Rossini, Fausto</creatorcontrib><creatorcontrib>Casaroli, Ivana</creatorcontrib><creatorcontrib>Pezzatti, Sara</creatorcontrib><creatorcontrib>Pogliani, Enrico Maria</creatorcontrib><creatorcontrib>Pioltelli, Pietro Enrico</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical lymphoma, myeloma and leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Belotti, Angelo</au><au>Doni, Elisa</au><au>Bolis, Silvia</au><au>Rossini, Fausto</au><au>Casaroli, Ivana</au><au>Pezzatti, Sara</au><au>Pogliani, Enrico Maria</au><au>Pioltelli, Pietro Enrico</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era</atitle><jtitle>Clinical lymphoma, myeloma and leukemia</jtitle><addtitle>Clin Lymphoma Myeloma Leuk</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>15</volume><issue>4</issue><spage>208</spage><epage>213</epage><pages>208-213</pages><issn>2152-2650</issn><eissn>2152-2669</eissn><abstract>Micro-Abstract The role of lymphocyte/monocyte ratio (LMR) in diffuse large B-cell lymphoma (DLBCL) is under investigation; its role in follicular lymphoma (FL) is unknown. We found a prognostic effect of LMR in FL and in DLBCL.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25468321</pmid><doi>10.1016/j.clml.2014.10.001</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2152-2650 |
| ispartof | Clinical lymphoma, myeloma and leukemia, 2015-04, Vol.15 (4), p.208-213 |
| issn | 2152-2650 2152-2669 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1667345247 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal, Murine-Derived - therapeutic use Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cyclophosphamide - therapeutic use Doxorubicin - therapeutic use Female Hematology, Oncology and Palliative Medicine Humans Leukocyte Count Lymphocytes Lymphoma, Follicular - blood Lymphoma, Follicular - diagnosis Lymphoma, Follicular - drug therapy Lymphoma, Follicular - mortality Lymphoma, Large B-Cell, Diffuse - blood Lymphoma, Large B-Cell, Diffuse - diagnosis Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - mortality Male Middle Aged Monocytes Neoplasm Staging Outside of a clinical trial Prednisone - therapeutic use Prognosis Retrospective Studies Rituximab - therapeutic use Survival Analysis Treatment Outcome Tumor burden Tumor microenvironment Vincristine - therapeutic use Watch and wait Young Adult |
| title | Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A16%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peripheral%20Blood%20Lymphocyte/Monocyte%20Ratio%20Predicts%20Outcome%20in%20Follicular%20Lymphoma%20and%20in%C2%A0Diffuse%20Large%20B-Cell%20Lymphoma%20Patients%20in%C2%A0the%C2%A0Rituximab%20Era&rft.jtitle=Clinical%20lymphoma,%20myeloma%20and%20leukemia&rft.au=Belotti,%20Angelo&rft.date=2015-04-01&rft.volume=15&rft.issue=4&rft.spage=208&rft.epage=213&rft.pages=208-213&rft.issn=2152-2650&rft.eissn=2152-2669&rft_id=info:doi/10.1016/j.clml.2014.10.001&rft_dat=%3Cproquest_cross%3E1667345247%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1667345247&rft_id=info:pmid/25468321&rft_els_id=S215226501400439X&rfr_iscdi=true |